Respiratory Function Monitoring in Rheumatologic Disorders

Core Parameters to Measure

The American Thoracic Society recommends monitoring respiratory function in rheumatologic disorders using spirometry (FEV1, FVC, FEV1/FVC ratio), diffusing capacity (DLCO), and lung volumes (TLC), with DLCO being particularly critical for detecting early interstitial lung disease and pulmonary vascular complications 1, 2
FEV1 measures airflow obstruction and tracks disease progression in patients with rheumatologic disorders, according to the European Respiratory Society 3, 1
FVC detects restrictive patterns common in rheumatologic lung involvement, as stated by the American College of Chest Physicians 1, 4
The FEV1/FVC ratio distinguishes obstructive from restrictive patterns and should be reported as a decimal fraction, not percentage, as recommended by the American Thoracic Society 1, 2
All spirometric indices must use the same reference value source to ensure consistency, according to the European Respiratory Journal 3, 5

The European Respiratory Society recommends using the Lower Limit of Normal (LLN), defined as the 5th percentile or z-score of -1.64, rather than arbitrary fixed percentages 1, 5, 2
Reference equations should match the patient's age, sex, height, and ethnicity, as stated by the American Thoracic Society 3, 5
All parameters should derive from the same reference source for consistency, according to the European Respiratory Journal 5

The American College of Rheumatology recommends performing complete pulmonary function testing including spirometry, DLCO, and lung volumes at diagnosis 1, 4
A >5% change in FEV1 or FVC indicates significant variation, according to the European Respiratory Society 2
A >12% change in FEV1 or >11% change in FVC from week to week suggests meaningful change, as stated by the American Thoracic Society 2
A >15% change in FEV1 from year to year indicates clinically meaningful progression, according to the European Respiratory Society 2

The American College of Chest Physicians recommends never confirming restrictive disease without measuring TLC, as reduced FVC on spirometry has poor positive predictive value for true restriction 2
The European Respiratory Society advises never relying solely on FEV1 to diagnose obstruction; always check the FEV1/FVC ratio first 2
The American Thoracic Society recommends measuring height with a stadiometer at each visit rather than relying on stated height 5